Home

Gilead Sciences, Inc. - Financial Overview

Ticker - GILD

Close PriceMarket CapP/E RatioForward P/E RatioImplied Growth*Implied Forward Growth*P/B Ratio
$104.54$130.32B275.114.143.6%7.8%6.7

Revenue and Net Income Chart EPS Chart
  Date Revenue Net Income EPS Revenue Change Net Income Change EPS Change
0 2020-12-31 $24.7B $123.0M $0.10 N/A N/A N/A
1 2021-12-31 $27.3B $6.2B $4.96 10.6% 4961.0% 4860.0%
2 2022-12-31 $27.3B $4.6B $3.66 -0.1% -26.2% -26.2%
3 2023-12-31 $27.1B $5.7B $4.54 -0.6% 23.4% 24.0%
4 2024-12-31 $28.8B $480.0M $4.54 6.0% -91.5% 0.0%
5 TTM 2024-12-31 $28.8B $480.0M $0.38 -0.0% 0.0% -91.6%
6 Average 3.2% 973.3% 953.2%




GILD - Forecast Data



GILD - Y/Y % Change

  Metric Value
0 Total Assets $58,995M
1 Cash $9,991M
2 Total Liabilities $39,749M
3 Total Debt $26,711M
4 Total Equity $19,330M
5 Debt to Equity Ratio 1.38
GILD Balance Sheet Chart



GILD - Valuation Chart


Valuation Chart

Share Price Treasury Yield Estimates Fair Value (P/E) Fair Value (P/S) Current P/S Current P/E
$104.54 4.3% Nicks Growth: 2%
Nick's Expected Margin: 15%
FINVIZ Growth: 25%
Nicks: 8
Finviz: 67
Nick's: 1.191 4.5 275.1
Basis Year Nicks Valuation Nicks vs Share Price Finviz Valuation Finviz vs Share Price
$0.38 EPS TTM $3.02 -97.1% $25.31 -75.8%
$7.86 EPS 2025 $62.41 -40.3% $523.56 400.8%
$8.30 EPS 2026 $65.90 -37.0% $552.87 428.9%